New Launch9 Jun 2025, 11:36 am
Kabra Drugs Ltd. Schedules Board Meeting to Discuss New Acquisition and Drug License
AI Summary
Kabra Drugs Ltd. has informed the BSE that a meeting of the Board of Directors is scheduled on June 18, 2025, at 5:00 PM in the Company's Chennai office. The agenda includes taking on record a new acquisition, a new drug license for the Chennai office, and the diversification by creating a new subsidiary. Any other agenda will be considered with the permission of the chair.
Key Highlights
- Kabra Drugs Ltd. Board Meeting on June 18, 2025
- New acquisition on the agenda
- New drug license for Chennai office
- Diversification by creating a new subsidiary
- Other agenda items with chair's permission